• Home
  • About
    • Our Constitution
    • Chairman’s words
    • Chairman and Board Members
  • Members
    • Become a Member
  • Annual Meetings
    • 1st Annual Meeting – 2010
    • 2nd Annual Meeting – 2011
    • 3rd Annual Meeting – 2012
    • 4th Annual Meeting -2013
    • 5th Annual Meeting- 2014
    • 7th Annual Meeting -2016
    • 8th Annual Meeting -2017
    • 9th Annual Meeting -2018
    • 10th Annual Meeting
    • 11th Annual Meeting
    • 12th Annual Meeting
  • Abstracts
    • Abstracts 2010
    • Abstracts 2011
    • Abstracts 2012
    • Abstracts 2014
    • Abstracts 2015
    • Abstracts 2016
    • Abstracts 2017
    • Abstracts 2018
    • Full Abstract List
  • Organizations
    • ISMFM
    • Israel Medical Association
    • Placenta – The Official Jourmal of IFPA
    • The Israel Fertility Association
    • SMFM
    • International Federation of Placenta Associations
    • The Endocrine Society of Australia
    • Nano Science
    • The Society for Reproductive Biology
    • Australasian Diabetes in Pregnancy Society
    • Society of Theriogenology
    • American College of Theriogenologists
    • The Fetal Medicine Foundation
  • Contact
Menu
  • Home
  • About
    • Our Constitution
    • Chairman’s words
    • Chairman and Board Members
  • Members
    • Become a Member
  • Annual Meetings
    • 1st Annual Meeting – 2010
    • 2nd Annual Meeting – 2011
    • 3rd Annual Meeting – 2012
    • 4th Annual Meeting -2013
    • 5th Annual Meeting- 2014
    • 7th Annual Meeting -2016
    • 8th Annual Meeting -2017
    • 9th Annual Meeting -2018
    • 10th Annual Meeting
    • 11th Annual Meeting
    • 12th Annual Meeting
  • Abstracts
    • Abstracts 2010
    • Abstracts 2011
    • Abstracts 2012
    • Abstracts 2014
    • Abstracts 2015
    • Abstracts 2016
    • Abstracts 2017
    • Abstracts 2018
    • Full Abstract List
  • Organizations
    • ISMFM
    • Israel Medical Association
    • Placenta – The Official Jourmal of IFPA
    • The Israel Fertility Association
    • SMFM
    • International Federation of Placenta Associations
    • The Endocrine Society of Australia
    • Nano Science
    • The Society for Reproductive Biology
    • Australasian Diabetes in Pregnancy Society
    • Society of Theriogenology
    • American College of Theriogenologists
    • The Fetal Medicine Foundation
  • Contact
Facebook
The Effect Of Cannabidiol On Placental Drug Transport In Normal, Term, Human Placentas.
Home ‹ 2012 Abstracts ‹ The Effect Of Cannabidiol On Placental Drug Transport In Normal, Term, Human Placentas.

Objective: The use of marijuana is associated with an increased risk for preterm birth. The aim of the current study was to examine the effects of cannabidiol (CBD) on placental drug transporters BCRP and P-gp.

Methods: Transplacental transport of Glyburide (BCRP substrate) and Digoxin (P-gp substrate) were examined. Cotyledons from term, normal placentas were dually perfused for 2 hours, with [n=6] or without [n=6] CBD (15μM). Glyburide was introduced to maternal (M) and fetal (F) compartments, while Digoxin was introduced only to the maternal compartment. Digoxin concentrations and F/M ratio of Glyburide concentrations were determined at different time points during the perfusion.

Results: [1] F/M ratios of Glyburide concentrations at 45,60,90 and 120min. were significantly higher (by 40-60%) in the presence of CBD (control – 0.85 vs CBD – 1.28) (fig.1) and [2] at the same time, CBD showed no significant influence on maternal-to-fetal transport of Digoxin (fig.2).

Conclusions: Our results show that BCRP is inhibited in the human placental barrier by exposure to CBD. However, it seems that this cannabinoid lacks the same impact on P-gp function in the human perfused cotyledon. The later observation may result from the low P-gp levels in term human placenta. These findings suggest that marijuana consumption affects the defense mechanisms of the human placenta against xenobiotics. This effect could jeopardize fetal wellbeing. Moreover, the safety of drugs that are BCRP substrates (i.e. glyburide, folic acid) which are used in pregnant women is questionable during cannabis consumption.

effect canabol

 

Authors:

Feinshtein Valeria.1, Ben-Zvi Zvi.1,Erez Offer.2, Eshkoli Tamar.2, Sheiner Eyal.2, Holcberg Gershon.2

1Department of Clinical Pharmacology, Faculty of Health Sciences, Ben Gurion University, Beer-Sheva, Israel.

2Department of Obstetrics and Gynecology, Soroka University Medical Center, Beer-Sheva, Israel.

 

« Previous
Next »
Powered by Netmii and Art + Web
All rights reserved to ISPR -Israel Society for Placental Research
Scroll to top